Chemexpress(SH:688131)2023-11-21 02:24Group 1: Company Strategy and Global Expansion - The company adheres to a global development strategy, utilizing international operations and management methods to accelerate overseas market expansion and establish a global sales network [2] - It has built multiple business centers worldwide and formed stable partnerships with multinational pharmaceutical giants and renowned research institutions [3] - The company aims to enhance brand influence and competitiveness while establishing a deep supply structure based in China to serve global customers [3] Group 2: Market Challenges and Responses - The global economic downturn and sluggish investment in biopharmaceuticals have led to a slowdown in the growth of the innovative drug industry, intensifying competition among domestic CDMO enterprises [3] - The company is focused on advancing its industrialization strategy and expanding its global market presence, particularly through the construction of new factories in Anhui, Shandong, and Qidong [3] - As a research-driven enterprise, the company is committed to understanding the latest developments in scientific research and drug development to support continuous product innovation [3] Group 3: Shareholder Actions and Stock Performance - The stock reduction primarily involves pre-IPO shareholders, driven by personal financial needs and the expiration of fund durations, which is a normal exit behavior for primary market financial investors [4] - The company strictly follows the regulations set by the CSRC and the stock exchange regarding share reduction and timely information disclosure [4]